Keyword Search
Legend:
CC = Vancouver Convention Centre F = Fairmont Waterfront Vancouver
* = applied session ! = JSM meeting theme
|
Keyword Search Criteria: development returned 68 record(s)
|
|
Sunday, 07/29/2018
|
The LISA 2020 Program to Build Statistics Capacity in Developing Countries
Eric Vance, LISA-University of Colorado Boulder
|
Statistical Approach for Investigating Change in Mutational Processes During Cancer Growth and Development
Zhi Yang, University of Southern California; Priyatama Pandey, University of Southern California; Darryl Shibata, University of Southern California; Paul Southern Marjoram, University of Southern California; Kimberly Siegmund, University of Southern California
|
Bridge the Gap Between Statistician and Data Analysis Professionals
Ming Li, Amazon
2:05 PM
|
MIDD: Perspectives and Possibilities
Dionne Price, Food and Drug Administration
2:05 PM
|
Statistical Development in Addressing Delayed Treatment Effect or Crossing Survival Curves in Immuno-Oncology Clinical Trials
Huyuan Yang, Takeda Oncology Pharmaceutical
2:20 PM
|
Use of Real-World in Clinical Drug Development
Xiuyu Julie Cong, Boehringer Ingelheim Pharmaceuticals Inc; Susan Wang, Boehringer Ingelheim Pharmaceuticals Inc.
3:05 PM
|
Statistical Approach for Investigating Change in Mutational Processes During Cancer Growth and Development
Zhi Yang, University of Southern California; Priyatama Pandey, University of Southern California; Darryl Shibata, University of Southern California; Paul Southern Marjoram, University of Southern California; Kimberly Siegmund, University of Southern California
3:30 PM
|
A Case Study on Model Based Meta-Analysis (MBMA) for Drug Development Decisions
Guohui Liu, Takeda Pharmaceuticals Inc ; Zhaoyang Teng, Takeda pharmaceuticals international, Co; Zhaowei Hua, Takeda Pharmaceuticals International Co.; Neeraj Gupta, Takeda pharmaceuticals international, Co; Richard Labotka, Takeda pharmaceuticals international, Co
3:35 PM
|
New Developments with the Sequential Parallel Comparison Design
Gheorghe Doros, Boston University; Denis Rybin, Pfizer, Inc
4:05 PM
|
Helping New Healthcare Researchers to Consider Statistics Early
Nicole Herrera, Children's National Medical Center; Heather Gordish-Dressman, Children's National Medical Center; James Bost, Children's National Medical Center
4:05 PM
|
A Glimpse into Industry Experience with RWE to Transform Pharmaceutical Research and Development
James Harnett
4:25 PM
|
Real World Evidence Demonstration Projects and Policy Development at FDA
Diqiong Xie, FDA; David Barrett Martin, FDA CDER OMP
4:45 PM
|
Practical Bayesian Modeling and Subgroup Inference in Alzheimer's Drug Development
Brad Carlin, University of Minnesota; Patrick Schnell, Ohio State University; Mark Fiecas, University of Minnesota; Peter Müller, University of Texas Austin; Qi Tang, Sanofi; Walter Offen, AbbVie
5:05 PM
|
|
Monday, 07/30/2018
|
Importance of Development of Soft Skills for Career Development for Statisticians in a Collaborative Environment
Jayawant Mandrekar, Mayo Clinic
|
Interacting with a Mentor: Tips and Strategies for a Successful Relationship
Sujata M Patil, Memorial Sloan Kettering Cancer Center
|
Assessing Treatment Benefit in Patient-Centric Study Designs
Jagadish Gogate, Johnson & Johnson-Janssen R&D
|
Preparing Future Leaders: Cultivating Communication with Wikipedia
Michelle M Wiest, University of Idaho; Christopher Williams, University of Idaho
8:35 AM
|
Large Scale Application of Mendelian Randomization for Systematic Causal Inferences Using GWAS Summary Statistics for Drug Discovery and Development
Xing Chen, Pfizer Inc WRD
9:05 AM
|
The Development of an Online Teaching Curriculum for PCORI's Methodology Standards
Elizabeth A Stuart, Johns Hopkins Bloomberg School of Public Health
9:35 AM
|
Development of the Canadian Marginalization Index Using Factor Analysis
Camille Charbonneau, Statistics Canada
9:35 AM
|
Two-Way Sparsity for Time-Varying Networks, with Applications in Genomics
Thomas Bartlett, University College London; Ricardo Silva, University College London; Ioannis Kosmidis, University of Warwick
9:50 AM
|
Recent Challenges in Vaccine Clinical Development
Tsai-Lien Lin, FDA/CBER
10:35 AM
|
Bridging to Bridges in Vaccine Development: Challenges in Comparing Multi-Serotype Vaccines
Jonathan Hartzel, Merck
10:55 AM
|
Matrix Decomposition for Modeling Multiple Sclerosis Lesion Development Processes
Menghan Hu, Brown University; Ani Eloyan, Brown University; Russell T. Shinohara, University of Pennsylvania Perelman School of Medicine; Ciprian Crainiceanu, Johns Hopkins University
11:05 AM
|
Estimating Unmet Need for Contraceptive Methods in the World's Poorest Countries
Leontine Alkema, University of Massachusetts Amherst; Niamh Cahill, University College Dublin; Chuchu Wei, University of Massachusetts Amherst
11:15 AM
|
An Analysis of MIMIC Data for Potential Surrogate Markers for Vaccine Development
Robert Small, Sanofi Pasteur; Pauline Jurvilliers, Sanofi Pasteur
11:20 AM
|
Maximum Diversity Weighting for Biomarkers with Application in HIV-1 Vaccine Studies
Zonglin He, Fred Hutchinson Cancer Research Center; Youyi Fong, Fred Hutchinson Cancer Research Center
11:55 AM
|
Beyond the Black Box: Flexible Algorithm Programming for Ecological Models in NIMBLE
Christopher Paciorek, University of California, Berkeley; Colin Lewis-Beck, Iowa State University; Perry de Valpine, UC Berkeley; Daniel B. Turek, Williams College; Lauren Ponisio, UC Riverside; Nick Michaud, UC Berkeley
2:05 PM
|
The Lean Course: Open and Collaborative Online Course Development
Sean Kross, The University of California San Diego
2:05 PM
|
An Application of 2-In-1 Adaptive Phase 2/3 Design for Expedited Oncology Drug Development
Xinqun (Maggie) Chen, Merck & Co., Inc.; Linda Sun, Merck & Co., Inc.; Cong Chen, Merck & Co.
2:05 PM
|
Extrapolation in Pediatric Drug Development: an Evolving Science
Yeruk Mulugeta, FDA; Lynne Yao, US FDA
2:05 PM
|
Critical Steps for Composite Endpoint Analysis
Jerry J. Li, Merck & Co., Inc.
2:20 PM
|
Using Data to Drive Curriculum Development
Chester Ivan Ismay, DataCamp
2:25 PM
|
A Generalized Design for a Confirmatory Basket Trial
Robert Beckman, Georgetown University; Xiaoyun (Nicole) Li, Merck
2:25 PM
|
Aligning Inference with the Tidyverse: Development of the Infer Package
Andrew Paul Bray, Reed College
3:05 PM
|
Statistical Considerations for Bridging Studies in Precision Medicine Programs with Drug-Device Co-Development
Shunguang Wang, Novartis Analytics; Meijuan Li, FDA; Xiaohong Li, Novartis Analytics; Jincao Wu, CDRH/US. Food and Drug Adminstration; Robinson Douglas, Novartis Pharmaceuticals
3:15 PM
|
|
Tuesday, 07/31/2018
|
Development and Comparison of Predictive Models for Woody Breast in Commercial Broilers
Andy Mauromoustakos, Univ. of Arkansas; JUAN P CALDAS-CUEVA, University of Arkansas; CASEY OWENS-HANNING, University of Arkansas
|
Analyzing Correlated Rare Events Data in Rodent Developmental Toxicology Studies
Shawn Harris, Social & Scientific Systems; Keith R. Shockley, National Institute of Environmental Health Sciences; Helen C. Cunny, National Institute of Environmental Health Sciences
|
Bayesian Methods in Real-World Evidence for Medicinal Product Development: Can Prior Distributions Provide a Platform for Creating Real-World Evidence?
John Loewy, Dataforethought
|
Career Advice for Statistics Educators in the Health Sciences
Felicity Enders, Mayo Clinic
|
Statistical Considerations for Bridging Studies in Precision Medicine Programs with Drug-Device Co-Development
Shunguang Wang, Novartis Analytics; Meijuan Li, FDA; Xiaohong Li, Novartis Analytics; Jincao Wu, CDRH/US. Food and Drug Adminstration; Robinson Douglas, Novartis Pharmaceuticals
|
Optimal Approach for Addressing Multiple Stakeholders' Requirements in Drug Development
Zoran Antonijevic
8:55 AM
|
Benefit Cost Ratio Analysis in Oncology Drug Development: Single Arm Vs RCT
Thomas Jemielita, Merck & Co.; Cong Chen, Merck & Co.
9:15 AM
|
Recent Developments in Modeling Nonlinear Relationships in the Presence of Measurement Error
Ruth Keogh, London School of Hygiene & Tropical Medicine; Christen Gray, London School of Hygiene & Tropical Medicine
9:50 AM
|
Statistical Methods for Single-Cell RNA-Seq in Studies of Mammalian Development
Christina Kendziorski, University of Wisconsin - Madison; Zijian Wang, University of Wisconsin - Madison; Ron Stewart, Morgridge Institute for Research; Chris Barry, Morgridge Institute for Research; Li-Fang Chu, Morgridge Institute for Research
10:35 AM
|
A Retrospective Control Study of the Millennium Villages Project
Shira Mitchell, Mathematica Policy Research; Andrew Gelman, Columbia University; Jeffrey Sachs, Columbia University; Avi Feller, UC Berkeley; Elizabeth A Stuart, Johns Hopkins Bloomberg School of Public Health; Alan Zaslavsky, Harvard University Medical School
10:35 AM
|
Assessment of Biomarkers and Surrogate Endpoints in Drug Development
Ivan Chan, AbbVie Inc; Shu-Chih Su, Merck Research Labs
10:55 AM
|
Statistical Graphics in Drug Development: Dose-Finding to Dossier Submission
Suddhasatta Acharyya, Novartis pharmaceuticals corporation
11:50 AM
|
A Bayesian Framework for Calculating Predictive Probability of Success in Biomarker Development
Cong Li; Ling Wang, Takeda; Ray Liu, Takeda Pharmaceuticals Inc
2:05 PM
|
Accelerating Product Development with Virtual Experimentation
Fred Hulting, General Mills, Inc.
2:25 PM
|
Detecting Developmental Expression Switches from Transcriptomic and Epigenomic Data
Claudia Kleinman, McGill University; Marie Forest, Lady Davis Research Institute, McGill University; Selin Jessa, McGill University; Celia M.T. Greenwood, Lady Davis Research Institute, McGill University
2:25 PM
|
Development of a Processed Cheese Food Safety Model Using a Response Surface Design and Parametric Survival Modeling
Francis Rossi, PepsiCo
2:45 PM
|
|
Wednesday, 08/01/2018
|
Preparing Statistician to Successfully Data Scientist in Big Data Era
Ming Li, Amazon
|
Statistical Approaches to Assess Early Life Exposure to Complex Mixtures and Associations with Latent Patterns of Neurodevelopmental Trajectories
Shelley H. Liu, Icahn School of Medicine at Mount Sinai; Brent A. Coull, Harvard TH Chan School of Public Health; Robert Wright, Icahn School of Medicine at Mount Sinai
|
Exposure-Response Analysis with Random Forest
Zifang Guo, Merck; Thomas Jemielita, Merck & Co.; John Kang, Merck
|
Impostor Syndrome
Rebecca W Doerge, Carnegie Mellon University ; Alicia Carriquiry, Iowa State University; Sastry Pantula, Oregon State University
8:35 AM
|
Statistical Approaches to Assess Early Life Exposure to Complex Mixtures and Associations with Latent Patterns of Neurodevelopmental Trajectories
Shelley H. Liu, Icahn School of Medicine at Mount Sinai; Brent A. Coull, Harvard TH Chan School of Public Health; Robert Wright, Icahn School of Medicine at Mount Sinai
8:50 AM
|
Exposure-Response Analysis with Random Forest
Zifang Guo, Merck; Thomas Jemielita, Merck & Co.; John Kang, Merck
10:00 AM
|
So You Think You Want to Be a Chair?
Karen Bandeen-Roche, Johns Hopkins University; Jeffrey Buzas, University of Vermont; Merlise Clyde, Duke University; Lloyd Edwards, University of Alabama at Birmingham
10:35 AM
|
A Statistical Framework on Clinical Trials for Information Integration Across Data Sources with Applications to Rare Disease Clinical Development
Yang Song, Vertex Pharmaceuticals Inc.; Xihao Li, Harvard T.H. Chan School of Public Health
10:55 AM
|
"Fostering Excellence" - Effective Leadership as a People Manager
Duane Snavely, Merck & Co.
11:15 AM
|
On Randomized Controlled Trials with Integrated Real World Evidence for Drug Development in Rare Diseases
Qing Liu, Amicus Therapeutics, Inc
11:15 AM
|
Bayes in Drug Development for Rare Diseases
John Scott, FDA
11:35 AM
|
Data for Good: Staying Sharp While Giving Back
David Corliss, Peace-Work
2:25 PM
|
Developments of the Synthetic Likelihood Approach for Bayesian Design for Models with Intractable Likelihoods
James McGree
2:45 PM
|
Project Redux: If I Knew Then What I Know Now
Mary J Kwasny, Northwestern University
3:05 PM
|
|
Thursday, 08/02/2018
|
Utilization of Historical Data and Real World Evidence in Clinical Trial Development - Case Studies in Rare Disease and Oncology
Florence H Yong, Pfizer Inc.; Ray Li, Pfizer Inc.; Steven Y Hua, Celgene - Receptos; Jeffery Palmer, Pfizer Inc.; Roberto Bugarini, Pfizer Inc.
8:50 AM
|
Statistical Challenges and Opportunities in Drug Development for Rare Diseases
Guowen Sun, BioMarin; Keith Gregg, BioMarin; Peter Slasor, BioMarin; Chito Hernandez, BioMarin Pharmaceutical Inc.
9:50 AM
|
|
|
